By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Serum Institute of India, Ltd. 

212/2, Hadapsar
Off Soli Poonawalla Road
Pune    411042  India
Phone: 91-20-26993900 Fax: 91-20-26993921


SEARCH JOBS


Industry
Pharmaceutical






Company News
Merck & Co., Inc. (MRK) and Serum Institute of India, Ltd. Announce Collaboration to Develop and Expand Global Access to Pneumococcal Conjugate Vaccine (PCV) 8/3/2011 8:01:24 AM
Billionaire-Led Serum Institute of India, Ltd.’s 50-Cent Vaccine Beats GlaxoSmithKline (GSK)’s Version in Study 6/16/2011 7:27:07 AM
Akorn, Inc. (AKN) Announces First ANDA Submission For Serum Institute of India, Ltd. 12/5/2007 1:08:17 PM
Dow Global Technologies Inc. Announces License Agreement with Serum Institute of India, Ltd. 2/27/2007 1:55:53 PM
Akorn, Inc. (AKRN) And Serum Institute of India, Ltd. Announce The Signing Of A Definitive Development And Exclusive Distribution Agreement For Rabies Monoclonal Antibody 11/8/2006 12:33:41 PM
Akorn, Inc. (AKRN) Announces Equity Investment By Serum Institute of India, Ltd. 9/8/2006 2:20:47 PM
Lipoxen (LPX.L) Raises £2.6 Million Through Strategic Placing And Warrant Agreement With Serum Institute of India, Ltd. 8/3/2006 5:20:10 PM
Akorn, Inc. (AKRN) And Serum Institute of India, Ltd. Announce The Signing Of An Exclusive Drug Development And Distribution Agreement For Oncology And Other Injectable Products10/19/2005 5:11:50 PM
//-->